Ghusn, Wissam
Cifuentes, Lizeth http://orcid.org/0000-0001-7865-2947
Anazco, Diego http://orcid.org/0000-0003-1829-7001
Fansa, Sima
Tama, Elif http://orcid.org/0009-0009-7595-9113
Campos, Alejandro http://orcid.org/0000-0002-6294-8652
Gala, Khushboo
Hurtado, Daniela Maria http://orcid.org/0000-0002-2322-7334
Acosta, Andres http://orcid.org/0000-0003-2286-489X
Article History
Received: 7 June 2023
Revised: 30 January 2024
Accepted: 1 February 2024
First Online: 28 February 2024
Competing interests
: Dr. Acosta is a stockholder in Gila Therapeutics, Phenomix Sciences; he served as a consultant for Rhythm Pharmaceuticals, Nestle, Structure Therapeutics and Amgen Pharmaceuticals. There are no other disclosures. All other authors declare no competing financial interests.